Overview
Start/End Dates
Locations
ICORD – Blusson Spinal Cord Centre
Name/Title
Andrea Maharaj, Clinical Research Facilitator
Phone
Email Address
Purpose of Study
The purpose of this study is to investigate the safety and effectiveness of non-invasive transcutaneous spinal cord stimulation (TSCS) in conjunction with conventional rehabilitation in helping with the recovery of bladder function in persons with spinal cord injury (SCI). The study team will assess immediate TSCS efficacy when the stimulation is turned on, as well as the persisting effects of TSCS (e.g. any changes in function) that remain after the stimulation is turned off and after several weeks of regular stimulation.
Health Canada has not approved the sale or use of this medical device for autonomic function recovery in individuals with spinal cord injury, although they have allowed its use in this clinical study.
Eligibility
This study is open to male and female B.C. residents between 19 to 65 years of age with an active provincial medical services plan. Participants must have an acute traumatic SCI (time since injury being 3-6 months) at or between C5 to T10 with AIS A or B and documented impaired bladder function. Participants must not be undergoing treatment or taking medications that may compromise patient safety, and cannot have implants (e.g. cardiac pacemaker or baclofen pump). Additionally, female participants must not be currently pregnant, lactating or intending to get pregnant during and 28 days after completing the study.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
The purpose of this study is to investigate the safety and effectiveness of non-invasive transcutaneous spinal cord stimulation (TSCS) in conjunction with conventional rehabilitation in helping with the recovery of bladder function in persons with spinal cord injury (SCI). The study team will assess immediate TSCS efficacy when the stimulation is turned on, as well as the persisting effects of TSCS (e.g. any changes in function) that remain after the stimulation is turned off and after several weeks of regular stimulation.
Health Canada has not approved the sale or use of this medical device for autonomic function recovery in individuals with spinal cord injury, although they have allowed its use in this clinical study.
This study is open to male and female B.C. residents between 19 to 65 years of age with an active provincial medical services plan. Participants must have an acute traumatic SCI (time since injury being 3-6 months) at or between C5 to T10 with AIS A or B and documented impaired bladder function. Participants must not be undergoing treatment or taking medications that may compromise patient safety, and cannot have implants (e.g. cardiac pacemaker or baclofen pump). Additionally, female participants must not be currently pregnant, lactating or intending to get pregnant during and 28 days after completing the study.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
